Download PDF
Synfacts 2022; 18(03): 0317
DOI: 10.1055/s-0041-1737842
Chemistry in Medicine and Biology

Process Development for the Synthesis of Hepatitis C NS5A Protein Inhibitor Odalasvir

Contributor(s):
Dirk Trauner
,
Belinda E. Hetzler
› Further Information
   Permissions and Reprints

Key words

large-scale synthesis - paracyclophane - hepatitis C - antiviral agents


Publication History

Article published online:
16 February 2022

© 2022. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany